Trial ID 20266

NCT04485013
clinicaltrials.gov ID
USOR ID: 20266 Phase Ib
A Phase 1a/1b Dose Escalation/Expansion Study of TTX-080, an HLA-G Antagonist, as Monotherapy and in Combination with Pembrolizumab or Cetuximab in Patients with Advanced Solid Refractory/Resistant Malignancies

Trial ID 20318

NCT04793958
clinicaltrials.gov ID
USOR ID: 20318 Phase III
A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy

Trial ID 20341

NCT04264702
clinicaltrials.gov ID
USOR ID: 20341
BESPOKE: Study of ctDNA Guided Therapy in Colorectal Cancer

Trial ID 20422

USOR ID: 20422
KRAS DetECT: KRAS mutation Detection to Evaluate Eligibility for Clinical Trials

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology